We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SAR market cap is 24.83M. The company's latest EPS is GBP -0.0317 and P/E is -7.26.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 47k | 0 | 0 | 0 | 0 |
| Operating Income | -1.13M | -1.73M | -2.59M | -4.04M | -4.67M |
| Net Income | -986k | -1.5M | -2.17M | -3.19M | -3.42M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 2M | 3.08M | 4.79M | 2.02M | 2.77M |
| Total Liabilities | 199k | 284k | 455k | 867k | 653k |
| Total Equity | 1.8M | 2.8M | 4.33M | 1.15M | 2.11M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -813k | -1.57M | -2.13M | -3.27M | -3.92M |
| Investing | 1,000 | -38k | -2k | N/A | 9k |
| Financing | 1.7M | 2.49M | 3.71M | N/A | 4.38M |
| Market Cap | 24.83M |
| Price to Earnings Ratio | -7.26 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 17.04 |
| Price to Book Ratio | 11.74 |
| Dividend Yield | - |
| Shares Outstanding | 107.95M |
| Average Volume (1 week) | 127.66k |
| Average Volume (1 Month) | 177.94k |
| 52 Week Change | -56.19% |
| 52 Week High | 52.50 |
| 52 Week Low | 10.20 |
| Spread (Intraday) | 2 (8.33%) |
| Company Name | Sareum Holdings Plc |
| Address |
unit 2a cambridge CB22 3FX |
| Website | https://www.sareum.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
